Common Contracts
3 similar Securities Purchase Agreement contracts by Lumera Corp, Novadel Pharma Inc, Transgenomic Inc
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 22nd, 2014 • Transgenomic Inc • Laboratory analytical instruments • New York
This Securities Purchase Agreement, dated on and as of the date set forth on the signature page hereto (this “Agreement”), is made between Transgenomic, Inc., a Delaware corporation (the “Company”), the undersigned purchaser(s) (each a “Purchaser” and collectively, the “Purchasers”) and each assignee of a Purchaser who becomes a party hereto.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 3rd, 2008 • Novadel Pharma Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”), dated as of May 6, 2008, is made among NovaDel Pharma Inc., a Delaware corporation (the “Company”), ProQuest Investments II, L.P., ProQuest Investments II Advisors Fund, L.P. and ProQuest Investments III, L.P. (each a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 8th, 2006 • Lumera Corp • Semiconductors & related devices • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of November 7, 2006 by and among Lumera Corporation, a Delaware corporation (the “Company”), and the purchaser(s) identified on the signature pages hereto (each a “Purchaser” and collectively, the “Purchasers”).
